NewGenIvf Announces Second Reverse Stock Split (1:3) in Four Months
NIVF sits 22% above its 52-week low of $0.472 on light trading volume (0.1× avg).
Summary
NewGenIvf Group Ltd announced a 1-for-3 reverse stock split effective July 6, 2026, reducing outstanding shares and marking the second such action in four months for the micro-cap company.
Key Events · Corporate Governance and Compliance · NIVF
-
Second Reverse Split Announced
NewGenIvf Group Ltd will implement a 1-for-3 reverse stock split, effective July 6, 2026, with trading on a split-adjusted basis beginning the same day.
-
Share Count Reduction
The split will reduce the number of outstanding Class A Ordinary Shares from approximately 10.26 million to 3.42 million.
-
Previous Split Context
This follows a 1-for-4 reverse split executed on March 16, 2026, highlighting ongoing challenges in maintaining share price and Nasdaq listing requirements.
-
Impact on Derivatives
All outstanding options, warrants, and other convertible securities will be adjusted by dividing the number of shares into which they are exercisable or convertible by three.
Analysis · NIVF · Industrial Applications And Services
This second reverse stock split in a short period (following a 1:4 split in March) is a critical negative development for NewGenIvf. It strongly suggests the company is struggling to maintain its Nasdaq listing requirements and that previous efforts to boost share price have failed. For a micro-cap already facing "going concern" warnings and having recently undergone significant dilution, this action signals severe financial distress and could lead to further erosion of investor confidence and share price.
At the time of this filing, NIVF was trading at $0.58 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.8M. The 52-week trading range was $0.47 to $372.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.